Janice Erica Chang

Janice Chang practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Janice Chang's NPI, 1154740470, was assigned on April 15, 2014. Janice Chang graduated from UC Irvine School of Medicine in 2014. Janice Chang's California license number on file is A139465.

Janice Chang's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Janice Chang's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Janice Chang is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Head & Neck Associates. Dmand AI also links Janice Chang to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Janice Chang practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Janice Chang's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Janice Chang is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Janice Chang has a license on file in California.

Dmand AI lists chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease and swimmer's ear among the conditions Janice Chang treats.

CMS data shows 807 Medicare services from Janice Chang across 7 procedure codes in 2024, for 362 Medicare patients. Medicare paid $80,051 for them. Every service was in an office.

CMS counts 362 Medicare patients who saw Janice Chang in 2024. The largest group is 65 to 74, with 156 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Janice Chang's median patient age at 59, with 55% women.

In 2024, Janice Chang wrote 724 Medicare Part D claims for 255 patients. 99% of them were for generic drugs. CMS names the drug for 647 of them, across 10 drugs with 11 or more claims each, at $19,364 in total drug cost. In 2023, CMS named 512 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Janice Chang for performance year 2024, reported as part of a group. Janice Chang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Janice Chang as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Janice Chang, published from 2012 to 2021. 2012 was the busiest year, with 3. Janice Chang's most frequent co-authors are Neil Bhattacharyya, FACS, MD and Nina Lisbeth Shapiro, MD.

CMS Open Payments shows 6 general payments to Janice Chang from 4 drug and device companies from 2018 to 2019. Food and beverage make up the largest share, 63% of the total. Smith & Nephew, Inc. paid the most, $230.

Janice Chang graduated from UC Irvine School of Medicine in 2014.

Janice Chang is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.